4
Tetrahedron
11
12
RT
RT
15
95
15
No desired product
-
____________________________________________________________________________________________________________
aImidazole N-oxide (1mmol), Oxalyl Chloride (2 mmol), Triethylamine (1.5 equiv) were ground and stirred at room temperature.
bIsolated yield from column chromatography.
On the basis of the experimental observations, a plausible
mechanism of cine substitution,12 is presumed to be operative
(Scheme 3). Thus, initially the imidazole N-oxide (1) is activated
by oxalyl chloride to form the imidazolium chloride (3), which is
then converted to the intermediate (4). The hydrogen atom at the
C-2 position, being now more acidic, is trapped by the base NEt3
to yield the desired product 2.
Scheme 3. Plausible mechanisms for solvent-free synthesis of substituted 2-chloroimidazole.
References and notes
3. Conclusions
In summary, we have developed an expeditious and mild
synthetic route for the chlorination at C-2 position of imidazole
N-oxide under solvent-free conditions leading to the formation of
2-chloroimidazole. The protocol has been tested with diversely
substituted N-phenyl group. In all cases, the yields are excellent,
though the presence of electron-withdrawing groups favors the
reaction over electron-donating substituents. 2-chlorinated
imidazole derivatives are useful intermediates and subunits of
several pharmacologically important compounds. This simple
setup and facile method could be attractive to the synthetic
chemists from academia and pharmaceutical industries. Further
application of this protocol in other heterocyclic systems is
underway in this laboratory.
1. Pastor I M, Yus M, Curr. Chem. Biol. 2009; 3: 65.
2. Frank PV, Girish KS, Kalluraya B. J Chem Sci. 2007; 119(1):41-
46.
3.
4.
Sharma D, Narasimhan B, Kumar P, Judge V, Narang RE, De
Clercq J. Balzarini, European Journal of Medicinal Chemistry.
2009; 44:2347-2353.
Shingalapur RV, Hosamani KM, Keri RS. European Journal of
Medicinal Chemistry. 2009; 44:4244-4248.
5. Raghavendra P, Veena G, Kumar GA, Kumar GR, Sangeetha N.
Rasyan J chem. 2011; 4:(1):91-102.
6. Hiroaki Yanagisawa, Yoshiya Amemiya, Takuro Kanazaki, Yasuo
Shimoji, Koichi Fujimoto, Yoshiko Kitahara, Toshio Sada,
Makoto Mizuno, Masahiro Ikeda, Shuichi Miyamoto, Youji
Furukawa, and Hiroyuki Koike.J. Med. Chem. 1996; 39: 323-338.
7.
Ozkay Y, Iskar I, Incesu Z, Akalın Ge. European Journal of
Medicinal Chemistry. 2010; 1-9.
8. Bonezzi K, Taraboletti G, Borsotti P, Bellina F, Rossi R, Giavazzi
R. J. Med. Chem. 2009; 52: 7906.
Supporting information
9. Jensen T R, Schaller C P, Hillmyer M A, Tolman W B. J.
Organomet. Chem. 2005; 690: 5881.
10. Stefan Laufer, Gerd Wagner, and Dunja Kotschenreuther. Angew.
Chem. Int. Ed. 2002; 41: No. 13.
11. I J Ferguson, K Schofield, J. Chem. Soc. Perkin Trans.1975; 1:
275- 277.
The detailed experimental section, all other information
such as melting point, FT-IR, NMR and Mass of all products are
provided in the supporting information.
12. Evgeny Adiulin, Anton V Kutasevich, Vitaly S. Mityanov, Iosif
Tkach, Tatyana Yu Koldaeva, Chemistry of Heterocyclic
Compounds. 2015; 51(5): 500–502.
AK. RSC Adv. 2016; 6; 10743-10749.
Acknowledgements
The author (MH) thanks UGC, New Delhi, for the award of
the fellowship under UGC-BSR Scheme. The author also
acknowledges CDRI, Lucknow for mass spectra.